A young lung transplant patient named Lynsey Scott died unfortunately after it emerged that she was given the lungs of a smoker.
Ms Scott was suffering from cystic fibrosis, which required that her lungs be replaced. However media reports indicate that the 28-year-old was not told about the fact that her donor was a smoker.
Advertisement
"We know Lynsey wouldn't have gone ahead had she known the donor was a smoker. The doctors took that choice away from her by not telling her," said her father Alan Scott. "She would have been horrified to have known those lungs were from a smoker."
Lynsey died last July following complications after her transplant surgery in February 2009. The University Hospitals South Manchester NHS Trust has revealed that it followed guidelines outlined by the NHS Blood and Transplant services.
"If there are factors or issues surrounding the donor deemed to make the donation of higher risk we will discuss these concerns directly with the recipient, such as drug use or a particular event in the donor's life," a Trust spokesman told The Sun.
Source: Medindia
"If there are factors or issues surrounding the donor deemed to make the donation of higher risk we will discuss these concerns directly with the recipient, such as drug use or a particular event in the donor's life," a Trust spokesman told The Sun.
Source: Medindia
Mesothelioma - Animation
Animation on mesothelioma - a form of lung cancer, that explains about the condition, its risk factors, diagnosis and treatment
Advertisement
Advertisement
|
Advertisement
Latest Organ Donation News
An analysis of data from donors suggests donor hearts from patients who were COVID-19 positive could place transplant patients at increased risk of mortality.
Patients subjected to delayed transplantation using 10°C static lung preservation had a better outcome compared to patients transplanted performed using standard methods.
Researchers are hoping to test the antibody IL-15 in organ transplant patients to reduce chronic organ rejection.
Research may speed the identification of patients who need liver transplants by analyzing blood samples to look for biomarkers associated with liver failure.
The discovery of T cells involvement in graft-versus-host disease is a vital step in finding more effective life-saving treatments for bone marrow transplant.